Ann: ACW Oversubscribed $3.9 million entitlement offer completed, page-6

Share price holding up surprisingly well (albeit on low volume) as newly issued shares from entitlement issue are tradeable from today. It appears new shares from ent issue are not being dumped (or not as yet anway?) as I expected some would sell newly issued heads and hang onto the free options.

I applied for considerable additional shares in the ent issue and received about 75%. I was thinking of selling the heads and hanging onto the free options myself but think i'll hang onto the heads too with the XanaCIDD P2 trial due "early Q3" ...